IL99539A0 - Fibrinogen receptor antagonists and pharmaceutical compositions containing them - Google Patents

Fibrinogen receptor antagonists and pharmaceutical compositions containing them

Info

Publication number
IL99539A0
IL99539A0 IL99539A IL9953991A IL99539A0 IL 99539 A0 IL99539 A0 IL 99539A0 IL 99539 A IL99539 A IL 99539A IL 9953991 A IL9953991 A IL 9953991A IL 99539 A0 IL99539 A0 IL 99539A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
receptor antagonists
fibrinogen receptor
fibrinogen
Prior art date
Application number
IL99539A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL99539A0 publication Critical patent/IL99539A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL99539A 1990-09-27 1991-09-20 Fibrinogen receptor antagonists and pharmaceutical compositions containing them IL99539A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58928290A 1990-09-27 1990-09-27

Publications (1)

Publication Number Publication Date
IL99539A0 true IL99539A0 (en) 1992-08-18

Family

ID=24357362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99539A IL99539A0 (en) 1990-09-27 1991-09-20 Fibrinogen receptor antagonists and pharmaceutical compositions containing them

Country Status (15)

Country Link
EP (1) EP0479481A3 (pt)
JP (1) JPH0517498A (pt)
KR (1) KR920006373A (pt)
CN (1) CN1060293A (pt)
AU (1) AU8477891A (pt)
CA (1) CA2052057A1 (pt)
CS (1) CS294791A3 (pt)
FI (1) FI914532A7 (pt)
HU (1) HUT60751A (pt)
IE (1) IE913380A1 (pt)
IL (1) IL99539A0 (pt)
MX (1) MX9101311A (pt)
NO (1) NO913786L (pt)
PT (1) PT99095A (pt)
ZA (1) ZA917695B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5340798A (en) * 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
JP3322878B2 (ja) * 1992-10-14 2002-09-09 メルク エンド カンパニー インコーポレーテッド フィブリノーゲンレセプターアンタゴニスト
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
WO1994008962A1 (en) * 1992-10-14 1994-04-28 Merck & Co., Inc. Fibrinogen receptor antagonists
WO1994012181A1 (en) * 1992-12-01 1994-06-09 Merck & Co., Inc. Fibrinogen receptor antagonists
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
SK47796A3 (en) * 1993-10-15 1997-03-05 Rhone Poulenc Rorer Pharma Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5451578A (en) * 1994-08-12 1995-09-19 Merck & Co., Inc. Fibrinogen receptor antagonists
US5525617A (en) * 1994-08-24 1996-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
AU754936B2 (en) * 1996-11-27 2002-11-28 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor

Also Published As

Publication number Publication date
CA2052057A1 (en) 1992-03-28
JPH0517498A (ja) 1993-01-26
HU913074D0 (en) 1992-01-28
MX9101311A (es) 1992-05-04
CN1060293A (zh) 1992-04-15
ZA917695B (en) 1992-05-27
EP0479481A2 (en) 1992-04-08
AU8477891A (en) 1992-04-02
IE913380A1 (en) 1992-04-08
EP0479481A3 (en) 1993-07-28
HUT60751A (en) 1992-10-28
FI914532A0 (fi) 1991-09-26
PT99095A (pt) 1992-08-31
NO913786D0 (no) 1991-09-26
CS294791A3 (en) 1992-04-15
NO913786L (no) 1992-03-30
FI914532A7 (fi) 1992-03-28
KR920006373A (ko) 1992-04-27

Similar Documents

Publication Publication Date Title
IL99246A0 (en) Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
IL103621A0 (en) Endothelin receptor antagonists and pharmaceutical compositions containing them
IL99957A0 (en) Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
IL99658A0 (en) Substituted azetidinones and pharmaceutical compositions containing them
IL96577A0 (en) Heterocyclic substituted acylaminothiazoles,their preparation and pharmaceutical compositions containing them
EP0479481A3 (en) Fibrinogen receptor antagonists
IL93090A0 (en) Platinum compounds and pharmaceutical compositions containing the same
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
IL98176A0 (en) Bicyclic 1-aza-cycloalkanes,their preparation and pharmaceutical compositions containing them
GB9405317D0 (en) Fibrinogen receptor antagonists
IL118325A0 (en) Integrin receptor antagonists and pharmaceutical compositions containing them
IL109782A0 (en) Imidazole-5-position substituted angiotensin II antagonists and pharmaceutical compositions containing them
HU9502028D0 (en) Fibrinogen receptor antagonists
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
HUP0002929A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
GB9320799D0 (en) Fibrinogen receptor antagonists
IL90637A (en) Neurokinin a antagonists and pharmaceutical compositions containing them
IL99561A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
IL98749A0 (en) Pharmaceutical compositions containing penciclovir
IL89155A0 (en) Ouabain-like compounds and pharmaceutical compositions containing them
IL99009A0 (en) Polypeptides,their preparation and pharmaceutical compositions containing them
IL98911A0 (en) 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them
HUP0003548A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
IL101482A0 (en) Substituted 2',3'-dideoxy-5-trifluoromethyluridines,and pharmaceutical compositions containing them